[Pharmacoeconomic aspects of lopinavir/ritonavir monotherapy]. / Aspectos farmacoeconómicos de la monoterapia con lopinavir potenciado con ritonavir.
Enferm Infecc Microbiol Clin
; 26 Suppl 16: 47-51, 2008 Dec.
Article
em Es
| MEDLINE
| ID: mdl-19572445
ABSTRACT
The present article briefly reviews the main types of pharmacoeconomic analyses that evaluate the costs associated with HIV infection and the efficiency of antiretroviral therapy in general. The results of several pharmacoeconomic analyses applied to the selection of antiretroviral drugs in distinct clinical scenarios are also presented. Finally, we analyze the advantages, in terms of efficiency, of lopinavir/ritonavir as induction-maintenance therapy, both in terms of saving the direct costs of treatment and in possibly reducing the costs due to the management of the adverse effects of nucleoside analogs.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Pirimidinonas
/
Infecções por HIV
/
Inibidores da Protease de HIV
/
Ritonavir
Idioma:
Es
Ano de publicação:
2008
Tipo de documento:
Article